Fabomotizole mesylate crostatin 2 Racemate for 24 hours

for 24 hours

C[C@@H](N)CC1=CN=CN1

The first CETP inhibitor

and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line

Fabomotizole mesylate crostatin 2 Racemate for 24 hoursFabomotizole, also known as Afobazole, is an anxiolytic drug launched in Russia in the early 2000s. It produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. Its mechanism of action remains poorly defined however, with GABAergic, NGF and BDNF release promoting, MT1 receptor agonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Fabomotizole was shown to inhibit MAO A reversibly